Company / EPS (Diluted)
NEUROONE MEDICAL TECHNOLOGIES Corp EPS (Diluted) History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.46
FY2025
5-year range
-$2.52 / -$0.46
FY2021-FY2025
Trend
+29.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 9 years, ranging from $-2.52 in FY2021 to $-0.01 in FY2016.
Based on SEC 10-K filings.
-0.46 in FY2025.
Improved from $-0.63 to $-0.46 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 29.2% year-over-year.
- Peak eps (diluted) was recorded in FY2016.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.46 | +29.2% |
| FY2024 | -$0.65 | -3.2% |
| FY2023 | -$0.63 | +32.3% |
| FY2022 | -$0.93 | +63.1% |
| FY2021 | -$2.52 | -25100.0% |
| FY2016 | -$0.01 | +0.0% |
| FY2015 | -$0.01 | +0.0% |
| FY2014 | -$0.01 | +0.0% |
| FY2012 | -$0.01 | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026